Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05099679 · ClinicalTrials.gov registry record · NA

Pilot Study for Black Men With Prostate Cancer: Optimization Of Mental and Heart Health, the BOOM-Heart Study

A NA study, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
14
Enrollment target

NCT05099679: Completed NA study, sponsored by Stanford University.

NCT05099679 is a NA study that has completed, run by Stanford University. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT05099679, a NA study, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
14 participants
Enrollment target

Study Summary

Pilot study to determine the feasibility of providing psychosocial and cardiac rehabilitation services to address socioeconomic health disparities and improve wellbeing for black men with prostate cancer.

Primary Outcome

Proportion of screened eligible participants who complete the initial 2-hour psychosocial support session intake. The pilot study is considered feasible if the primary endpoint is met in at least 50% of patients. We will evaluate the 95% CI of the feasibility rate.

Interventions

  • BEHAVIORAL Cognitive behavioral therapy (supportive counseling)
  • BEHAVIORAL Virtual Cardiac Rehabilitation

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2021-11-18
Est. Completion 2024-12-20
Phase NA
Stanford University

1,744 total trials

What the finished NCT05099679 record still lists

NCT05099679 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Cognitive behavioral therapy (supportive counseling) is the first listed.

NCT05099679 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05099679 about?

NCT05099679 is a clinical study titled "Pilot Study for Black Men With Prostate Cancer: Optimization Of Mental and Heart Health, the BOOM-Heart Study". Pilot study to determine the feasibility of providing psychosocial and cardiac rehabilitation services to address socioeconomic health disparities and improve wellbeing for black men with prostate cancer.

What is the current status of trial NCT05099679?

This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2021-11-18. Estimated completion is 2024-12-20.

What interventions are being tested in trial NCT05099679?

The interventions under investigation include: Cognitive behavioral therapy (supportive counseling) (BEHAVIORAL), Virtual Cardiac Rehabilitation (BEHAVIORAL).

Who is sponsoring clinical trial NCT05099679?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05099679's enrollment target sits among peer trials

14 1909th of 2000 higher than 90 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02523092 · 14 participants · Phase 4

    Use of CXCL9 as a Biomarker of Acthar Efficacy

  • NCT04263285 · 14 participants · NA

    Treatment of Depression Post-SCI

  • NCT04743271 · 14 participants · NA

    Food and Circadian Timing

  • NCT05065671 · 14 participants · Phase 1

    Microbiome Derived Metabolism and Pharmacokinetics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT05099679, the US trial registry maintained by the National Library of Medicine. NCT05099679 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.